JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barkett, M.
Right arrow Articles by Gilmore, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barkett, M.
Right arrow Articles by Gilmore, T. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 47, Issue of November 21, 1997 pp. 29419-29422

COMMUNICATION:
Phosphorylation of Ikappa B-alpha Inhibits Its Cleavage by Caspase CPP32 in Vitro*

(Received for publication, May 29, 1997, and in revised form, September 12, 1997)

Margaret Barkett Dagger §, Ding Xue par , H. Robert Horvitz ** and Thomas D. Gilmore Dagger Dagger Dagger

From the Dagger  Department of Biology, Boston University, Boston, Massachusetts 02215 and the  Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Ikappa B proteins function as direct regulators of Rel/NF-kappa B transcription complexes. We show that the cell-death protease CPP32 (caspase-3) in vitro specifically cleaved chicken and human Ikappa B-alpha at a conserved Asp-Ser sequence. This cleavage site appears to be identical to the site at which chicken Ikappa B-alpha is cleaved in vivo in temperature-sensitive v-Rel-transformed chicken spleen cells undergoing apoptosis. Other caspases, namely interleukin-1beta -converting enzyme (caspase-1) and Ich-1 (caspase-2), did not cleave Ikappa B-alpha . CPP32 also cleaved mammalian Ikappa B-beta in vitro at the analogous Asp-Ser sequence. Cleavage of Ikappa B-alpha by CPP32 was blocked by serine phosphorylation of Ikappa B-alpha . Cleavage of Ikappa B-alpha by a CPP32- like protease could generate a constitutive inhibitor of Rel transcription complexes. This report provides evidence for a direct biochemical interaction between the NF-kappa B signaling pathway and a cell-death protease signaling pathway.


INTRODUCTION

Apoptosis is a form of regulated programmed cell death that is involved in normal development and organ homeostasis (reviewed in Ref. 1). One cellular pathway leading to apoptosis involves a family of related cysteine proteases (caspases) first defined by the Caenorhabditis elegans cell-death protease CED-3 and the interleukin-1beta -converting enzyme (ICE)1 (reviewed in Refs. 2 and 3). Although all caspases cleave C-terminal to Asp residues, individual proteases show distinct substrate specificities in vitro and can be divided into subfamilies based on substrate preference (3, 4). The caspase CPP32 shows a substrate specificity similar to that of CED-3, and CPP32 appears to be an important cell-death protease in vertebrates. For example, mice with a disruption of the gene encoding CPP32 have reduced neural cell death (5). It is likely that in many cell types specific cell-death proteases are activated in a sequential manner to lead to cell death (6). Thus, one class of in vivo substrates for the cell-death proteases includes the caspases themselves. In addition, several other proteins have been identified as substrates for caspases (reviewed in Ref. 3).

The Ikappa B proteins comprise a conserved family of proteins that act as regulators of the Rel/NF-kappa B family of transcription factors (reviewed in Ref. 7). Ikappa B proteins are structurally related in that they all have a central core of ankyrin repeats that are essential for interaction with Rel complexes. Interaction of an Ikappa B protein with a Rel complex usually results in retention of the Rel complex in the cytoplasm and inhibition of the DNA binding activity of the Rel complex.

In the best characterized case, Ikappa B-alpha interacts with and inhibits the activity of NF-kappa B. In response to a variety of signals, Ikappa B-alpha becomes phosphorylated on two Ser residues in its N-terminal regulatory domain (8-10). This N-terminal phosphorylation leads to ubiquitination of Ikappa B-alpha at nearby Lys residues, thereby targeting Ikappa B-alpha for cleavage by the proteasome (11-13). The free NF-kappa B complex can then enter the nucleus and affect gene transcription.

We have previously shown that Ikappa B-alpha undergoes a specific N-terminal cleavage in chicken spleen cells transformed by a temperature-sensitive mutant of the retroviral oncoprotein v-Rel when these cells are induced to undergo apoptosis by a shift to the nonpermissive temperature (14). This observation led us to suggest that Ikappa B-alpha might be a direct substrate for a cell-death protease, which could cleave Ikappa B-alpha at a conserved Asp near the N terminus (Fig. 1A; Ref. 15).


Fig. 1. Cleavage of chicken Ikappa B-alpha (p40) by CPP32. A, shown is the conserved region of signal-induced serine (bold S) phosphorylation in the indicated Ikappa B proteins (Hu, human; Ch, chicken; Mu, murine); relevant amino acid residues are indicated above each sequence. DEVD is the sequence of a potent inhibitor of CPP32, and the predicted cleavage site C-terminal to the aspartate residue is indicated by the arrow. B, specific cleavage of p40 by CPP32. In vitro translated, radiolabeled p40 was incubated without (-) or with (+) the indicated proteases. C, p40 was incubated without (-) or with (+) CPP32 and in the absence (-) or presence (+) of the tetrapeptide inhibitor Ac-Asp-Glu-Val-Asp-aldehyde (DEVD). In B and C, samples were analyzed by SDS-PAGE followed by autoradiography and phosphorimaging, respectively. The positions of full-length p40 and cleaved p40 (Delta N) are indicated by arrows.

[View Larger Version of this Image (27K GIF file)]


In this report, we show that Ikappa B-alpha is a substrate for CPP32 in vitro. Cleavage of Ikappa B-alpha by CPP32 could create a dominant inhibitor of Rel transcription complexes.


EXPERIMENTAL PROCEDURES

Cells

Chicken spleen cell lines transformed by ts mutant v-G37E were cultured in Temin's modified Eagle's medium containing 20% fetal bovine serum as described previously (14).

Plasmids and in Vitro Mutagenesis

Site-directed mutagenesis of p40 was performed using the method of Kunkel (16), as described previously (17). An EcoRI to HincII fragment from an Ikappa B-alpha /p40 cDNA was first subcloned into M13mp19. The following oligonucleotides were used on single-stranded DNA templates to create the indicated Ikappa B-alpha /p40 mutants: D35A, 5'-GACGACCGCCACGCCAGCGGGCTGGAC-3'; D39A, 5'-GACCGCCACGACAGCGGGCTGGCCTCCATG-3'; S36A/S40A, 5'-CGCCACGACGCCGGGCTGGACGCCATGAAG-3'; S36E/S40E, 5'-GACCGCCACGACGAAGGGCTGGACGAACTGAAG-3'. The D35A mutation introduced a BstXI site that was used in screening for other mutations. All mutations were confirmed by DNA sequencing.

To create in vitro expression vectors for Ikappa B-alpha /p40, human Ikappa B-alpha , and mouse Ikappa B-beta , cDNAs were subcloned into pGEM4. An EcoRI to HincII fragment containing wild-type p40 sequences was subcloned into pGEM4 digested with EcoRI and HincII; expression vectors for mutant Ikappa B-alpha /p40 proteins were made by replacing wild-type sequences with appropriate mutant fragments. Wild-type and D31A human Ikappa B-alpha inserts were subcloned as KpnI to NotI/Klenow-treated fragments into pGEM4 digested with KpnI and HincII. An EcoRI to XhoI fragment from a mouse Ikappa B-beta cDNA was subcloned into pGEM4 digested with EcoRI and SalI.

In Vitro Cleavage by Caspases

All in vitro translations were performed in the TNT-coupled wheat germ extract (Promega) using SP6 polymerase in the presence of Tran35S-label (Amersham Corp.). Cleavage of in vitro translated proteins by individual caspases was performed as described previously (4). Briefly, in vitro translated substrate proteins were incubated in CED-3 buffer (50 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5 mM sucrose, 5% glycerol) with approximately 40 ng of a given bacterially produced and purified enzyme for 2-6 h at 30 or 37°C. Where indicated, the CPP32 inhibitor Ac-Asp-Glu-Val-Asp-aldehyde (DEVD; Bachem) was included at a concentration of 50 µM. Phosphorylation of in vitro translated p40 was carried out with purified Ikappa B kinase as described previously (18). Phosphorylated p40 was dephosphorylated by treatment with calf intestinal phosphatase (Boehringer Mannheim) for 45 min at 30°C. Samples were separated on SDS-PAGE, and 35S-labeled proteins were detected by autoradiography or using a phosphorimager (Bio-Rad).

Western Blotting

Western blotting was performed as described previously (14) using anti-Rel primary antiserum (1:500) (19) or an anti-p40 monoclonal antibody (anti-ANK; HY95) (1:2500) (14). The appropriate secondary antiserum was added, and complexes were detected by enhanced chemiluminescence (Amersham) and autoradiography.


RESULTS

Chicken Ikappa B-alpha (p40) Is a Substrate for CPP32 in Vitro

To determine whether chicken Ikappa B-alpha (called p40 hereafter) could serve as a direct substrate of a caspase, in vitro translated p40 was incubated with bacterially expressed and purified ICE, CPP32, and Ich-1, which represent apparently distinct classes of enzymes within the caspase family (2, 4). p40 was specifically cleaved by CPP32, but not by ICE or Ich-1 (Fig. 1B). Cleavage of p40 in vitro by CPP32 was inhibited by Ac-Asp-Glu-Val-Asp-aldehyde (DEVD), a specific peptide inhibitor of CPP32-like proteases (Fig. 1, A and C). Thus, p40 is a substrate of CPP32 in vitro.

CPP32 Cleaves p40 between Asp-35 and Ser-36

CPP32-like proteases cleave C-terminal to Asp residues that are frequently followed by Gly, Ser, or Ala and that are often in the consensus sequence Asp-X-X-Asp-Gly/Ser/Ala (3). There is a potential CPP32 cleavage site (Asp-Arg-His-Asp-Ser-Gly-Leu-Asp-Ser, aa 32-40; Fig. 1A) between aa 35 and 36 of p40. To determine if this was the site of CPP32 cleavage in p40, mutants with site-directed changes in p40 were incubated with CPP32 (Fig. 2, A and B). Mutant D35A, in which the predicted Asp cleavage site was changed to an Ala, was not detectably cleaved by CPP32. In contrast p40 mutant D39A was cleaved by CPP32 to a similar extent as wild-type p40. The cleaved form of p40 is not recognized by a monoclonal antibody directed against the N terminus of p40, indicating that CPP32 cleaved near the N terminus of p40 in vitro (data not shown; Ref. 14). These results indicate that CPP32 cleaved p40 between Asp-35 and Ser-36.


Fig. 2. Identification of the site of CPP32 cleavage in p40. A, sequences of site-directed mutants in p40. B, the indicated p40 proteins were translated in vitro and incubated without (-) and with (+) CPP32. Samples were separated by SDS-PAGE, and proteins were detected by autoradiography.

[View Larger Version of this Image (24K GIF file)]


In Vitro Cleaved p40 Co-migrates on SDS-Polyacrylamide Gels with in Vivo Cleaved p40

We previously showed that p40 is cleaved near its N terminus in chicken spleen cells transformed by ts v-Rel mutant v-G37E when these cells are induced to undergo apoptosis by a shift to the nonpermissive temperature (14, 15). As shown in Fig. 3, A and B, the proteolyzed form of p40 generated by in vitro cleavage with CPP32 co-migrates on SDS-polyacrylamide gels with the major N-terminally truncated form of p40 seen in ts v-Rel-transformed cells undergoing apoptosis. This result suggests that the N-terminal cleavage of p40 in vitro by CPP32 is identical to the cleavage of p40 that occurs in ts v-G37E-transformed chicken spleen cells undergoing apoptosis.


Fig. 3. p40 cleaved with CPP32 in vitro co-migrates with p40 cleaved in ts v-Rel-transformed cells undergoing apoptosis. In vitro translated, radiolabeled p40 (first two lanes) was incubated without (-) or with (+) CPP32. The third lane of this gel contains an unlabeled lysate from ts v-G37E-transformed spleen cells that had been shifted to the nonpermissive temperature for 48 h. Samples were transferred to a filter that was exposed to film directly (A) or probed by Western blotting with an anti-p40 monoclonal antibody (B). To equalize the images, the first two lanes in B are from a longer exposure than in the third lane. p40 indicates full-length p40; Delta N indicates the N-terminally cleaved form of p40.

[View Larger Version of this Image (29K GIF file)]


Phosphorylation at Sites of Signal-induced Phosphorylation Blocks the Ability of Chicken p40 to Serve as a Substrate for CPP32

Ser-36 and Ser-40, which are located just beyond Asp-35 (the site of CPP32 cleavage) in p40, are sites of signal-induced phosphorylation (8-10). Phosphorylation at these Ser residues can be mimicked by Glu substitutions at these sites (8), and Ikappa B-alpha can be phosphorylated in vitro at these Ser residues by a purified MEKK1-activated kinase from HeLa cells (18). To determine whether phosphorylation at these Ser residues affects the ability of p40 to serve as a substrate for CPP32, we tested whether p40 double mutant S36E/S40E as well as in vitro phosphorylated p40 could be cleaved by CPP32 in vitro (Fig. 4). Neither the S36E/S40E mutant nor wild-type p40 phosphorylated at Ser-36 and Ser-40 in vitro was cleaved by CPP32. In contrast, p40 mutant S36A/S40A (Ser right-arrow Ala) was cleaved by CPP32 to the same extent as wild-type nonphosphorylated p40. Treatment of phosphorylated p40 with calf intestinal phosphatase rendered p40 susceptible to cleavage by CPP32. Taken together, these results suggest that signal-induced phosphorylation of Ikappa B-alpha in vivo would block its ability to be cleaved by a CPP32-like protease(s).


Fig. 4. Phosphorylated p40 is not a substrate for CPP32. A, wild-type p40 and the indicated p40 mutants were incubated without (-) or with (+) CPP32. B, p40 was translated in vitro and, where indicated, treated with MEKK1-activated Ikappa B-alpha kinase (lanes 3, 4, and 9-12) and/or calf intestinal phosphatase (lanes 7, 8, 11, and 12). The phosphorylated form of p40 (pp40) migrates as a doublet with a slower mobility than nonphosphorylated p40. As indicated, samples were then incubated without (-) or with (+) CPP32. All samples were analyzed as described for Fig. 1.

[View Larger Version of this Image (34K GIF file)]


Other Vertebrate Ikappa B Proteins Can Also Be Cleaved by CPP32

The Asp-Ser sequence at aa 35-36 of chicken Ikappa B-alpha /p40 is conserved in mammalian Ikappa B-alpha and Ikappa B-beta (aa 31-32 in human Ikappa B-alpha and aa 19-20 in mouse Ikappa B-beta ; Fig. 1A). To determine whether these mammalian Ikappa B proteins could also serve as substrates for CPP32, in vitro translated human Ikappa B-alpha and mouse Ikappa B-beta were incubated with CPP32 (Fig. 5). Each mammalian Ikappa B protein was cleaved by CPP32 to a size consistent with cleavage at this Asp-Ser sequence. Furthermore, human Ikappa B-alpha mutant D31A, containing a mutation at the predicted Asp cleavage site, was not cleaved by CPP32. Thus, mammalian Ikappa B proteins can also be cleaved by CPP32 in vitro.


Fig. 5. Cleavage of mammalian Ikappa B proteins by CPP32. The indicated radiolabeled proteins were incubated without (-) or with (+) CPP32, and samples were analyzed as described for Fig. 1.

[View Larger Version of this Image (34K GIF file)]



DISCUSSION

In this report, we describe biochemical evidence for a link between an apoptosis pathway and the Rel/NF-kappa B signal transduction pathway. Specifically, we have shown that Ikappa B proteins can serve in vitro as direct substrates for the cell-death protease CPP32. In addition, the chicken p40 cleavage product generated by in vitro cleavage with CPP32 appears to be identical to that generated in vivo in temperature-sensitive v-Rel-transformed cells undergoing apoptosis (14, 15). CPP32 is expressed in these cells,2 indicating that CPP32 may be the in vivo cleaving activity; however, we cannot exclude the possibility that a related protease cleaves p40 in these cells.

Three observations indicate that cleavage of p40 is not essential for the apoptosis that occurs in ts v-Rel-transformed cells shifted to the nonpermissive temperature. First, cleavage of p40 is a late event in ts v-Rel-transformed spleen cells undergoing apoptosis (14). Second, Bcl-2 blocks apoptosis in these cells but does not block cleavage of p40 (15). Third, CrmA (a cowpox virus-encoded inhibitor of caspases) blocks N-terminal cleavage of p40 in these cells but does not block apoptosis (15).

Our results indicate that cleavage of Ikappa B-alpha by a CPP32-like protease is distinct from signal-induced, proteasome-mediated cleavage of Ikappa B-alpha . Namely, signal-induced cleavage of Ikappa B-alpha requires phosphorylation at two N-terminal Ser residues, whereas phosphorylation or mutations that mimic phosphorylation at these Ser residues block the ability of CPP32 to cleave Ikappa B-alpha . Therefore, we appear to have identified a novel pathway for proteolysis of Ikappa B-alpha .

Overexpression of an N-terminally deleted form of Ikappa B-alpha , which is resistant to ubiquitination-based degradation, prevents activation of NF-kappa B (20). Therefore, cleavage of Ikappa B-alpha by a CPP32-like protease could create what is sometimes called a super-repressor form of Ikappa B-alpha (20). That is, cleavage by CPP32 would block the ability of Ikappa B-alpha to undergo signal-induced degradation by removing the sites of signal-induced ubiquitination and by likely disrupting the ability of Ikappa B-alpha to become phosphorylated at critical Ser residues. Therefore, cleavage of Ikappa B-alpha by CPP32 would block activation of Rel/NF-kappa B complexes and their responsive genes.

Activation of the tumor necrosis factor receptor has recently been shown to induce two conflicting pathways, one leading to CPP32-mediated apoptosis and one leading to activation of NF-kappa B, which is anti-apoptotic (20-23). Inhibition of NF-kappa B activation by a noninducible form of Ikappa B-alpha renders cells more susceptible to tumor necrosis factor-induced apoptosis (20, 21, 23). Therefore, cleavage of Ikappa B-alpha by a CPP32-like protease may act to facilitate, rather than effect, apoptosis.


FOOTNOTES

*   This work was supported by National Cancer Institute Grant CA47763 (to T. D. G.), the Council for Tobacco Research, Inc. (to T. D. G.), National Institutes of Health Shared Instrumentation Grant RR11397 (to T. D. G.), and the Howard Hughes Medical Institute (to H. R. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Partially supported by National Institutes of Health Molecular Biophysics Training Grant GM08291.
par    Supported by Fellowships from the Anna Fuller Fund and the Helen Hay Whitney Foundation.
**   Investigator of the Howard Hughes Medical Institute.
Dagger Dagger    Partially supported by an American Cancer Society Faculty Research Award. To whom correspondence should be addressed: Boston University, Biology Dept., 5 Cummington St., Boston, MA 02215-2406. Tel.: 617-353-5444; Fax: 617-353-6340; E-mail: gilmore{at}bio.bu.edu.
1   The abbreviations used are: ICE, interleukin-1beta -converting enzyme; aa, amino acid(s); PAGE, polyacrylamide gel electrophoresis.
2   M. Barkett and T. D. Gilmore, unpublished results.

ACKNOWLEDGEMENTS

We thank G. Pitoc for excellent technical assistance, Drs. D. White and S. Shaham for helpful discussions, K. Lee for help with plasmid constructions, Drs. T. Maniatis and F. Lee for generously providing in vitro phosphorylated p40, Drs. D. Baltimore and X. Yang for Ikappa B-beta , Dr. M. Karin for human Ikappa B-alpha and mutant D31A, Drs. C. Li and J. Celenza for help with figures, and Dr. J.-C. Epinat for help with purification of CPP32.


REFERENCES

  1. Jacobson, M. D., Weil, M., and Raff, M. (1997) Cell 88, 347-354 [CrossRef][Medline] [Order article via Infotrieve]
  2. Chinnaiyan, A., and Dixit, V. (1996) Curr. Biol. 6, 555-562 [CrossRef][Medline] [Order article via Infotrieve]
  3. Nicholson, D. W., and Thornberry, N. A. (1997) Trends Biochem. Sci. 22, 299-306 [CrossRef][Medline] [Order article via Infotrieve]
  4. Xue, D., Shaham, S., and Horvitz, H. R. (1996) Genes Dev. 10, 1073-1083 [Abstract/Free Full Text]
  5. Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karauyama, H., Rakic, P., and Flavell, R. A. (1996) Nature 384, 368-372 [CrossRef][Medline] [Order article via Infotrieve]
  6. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. (1996) Nature 380, 723-726 [CrossRef][Medline] [Order article via Infotrieve]
  7. Gilmore, T. D., and Morin, P. J. (1993) Trends Genet. 9, 427-433 [CrossRef][Medline] [Order article via Infotrieve]
  8. Brockman, J. A., Sherer, D. C., McKinnsey, T. A., Hall, S. A., Qi, X., Lee, W. H., and Ballard, D. W. (1995) Mol. Cell. Biol. 15, 2809-2818 [Abstract]
  9. Brown, K., Gerstburger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995) Science 267, 1485-1488 [Abstract/Free Full Text]
  10. Traenckner, E. B.-M., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., and Baeuerle, P. A. (1995) EMBO J. 14, 2876-2883 [Medline] [Order article via Infotrieve]
  11. Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. (1995) Genes Dev. 9, 1586-1597 [Abstract/Free Full Text]
  12. Baldi, L., Brown, K., Franzoso, G., and Siebenlist, U. (1996) J. Biol. Chem. 271, 376-379 [Abstract/Free Full Text]
  13. Rodriguez, M. S., Wright, J., Thompson, J., Thomas, D., Baleux, F., Virelizier, J.-L., Hay, R. T., and Arenzana-Seisdedos, F. (1996) Oncogene 12, 2425-2435 [Medline] [Order article via Infotrieve]
  14. White, D. W., Roy, A., and Gilmore, T. D. (1995) Oncogene 10, 857-868 [Medline] [Order article via Infotrieve]
  15. White, D. W., and Gilmore, T. D. (1996) Oncogene 13, 891-899 [Medline] [Order article via Infotrieve]
  16. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492 [Abstract/Free Full Text]
  17. White, D. W., and Gilmore, T. D. (1993) J. Virol. 67, 6876-6881 [Abstract/Free Full Text]
  18. Lee, F. S., Jagler, J., Chen, Z. J., and Maniatis, T. (1997) Cell 88, 213-222 [CrossRef][Medline] [Order article via Infotrieve]
  19. Gilmore, T. D., and Temin, H. M. (1986) Cell 44, 791-800 [CrossRef][Medline] [Order article via Infotrieve]
  20. Wang, C.-Y., Mayo, M. W., and Baldwin, A. S., Jr. (1996) Science 274, 784-787 [Abstract/Free Full Text]
  21. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Science 274, 787-789 [Abstract/Free Full Text]
  22. Beg, A. A., and Baltimore, D. (1996) Science 274, 782-784 [Abstract/Free Full Text]
  23. Liu, Z.-g., Hsu, H., Goeddel, D. V., and Karin, M. (1996) Cell 87, 565-575 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 47, Issue of November 21, 1997 pp. 29419-29422
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Zaragoza, M. Saura, E. Y. Padalko, E. Lopez-Rivera, T. R. Lizarbe, S. Lamas, and C. J. Lowenstein
Viral protease cleavage of inhibitor of {kappa}B{alpha} triggers host cell apoptosis
PNAS, December 12, 2006; 103(50): 19051 - 19056.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. C. Taggart, S.-A. Cryan, S. Weldon, A. Gibbons, C. M. Greene, E. Kelly, T. B. Low, S. J. O'Neill, and N. G. McElvaney
Secretory leucoprotease inhibitor binds to NF-{kappa}B binding sites in monocytes and inhibits p65 binding
J. Exp. Med., December 19, 2005; 202(12): 1659 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J.-H. CHANG, Y.-T. WANG, and H.-M. CHANG
Pectinesterase Inhibitor from Jelly Fig (Ficus awkeotsang Makino) Achene Induces Apoptosis of Human Leukemic U937 Cells
Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 506 - 515.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Kato, H. Fukuda, T. Nonaka, and S. Imajoh-Ohmi
Cleavage of Nonmuscle Myosin Heavy Chain-A during Apoptosis in Human Jurkat T Cells
J. Biochem., February 1, 2005; 137(2): 157 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Rathore, H. Matta, and P. M. Chaudhary
An Evolutionary Conserved Pathway of Nuclear Factor-{kappa}B Activation Involving Caspase-mediated Cleavage and N-end Rule Pathway-mediated Degradation of I{kappa}B{alpha}
J. Biol. Chem., September 17, 2004; 279(38): 39358 - 39365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Ho, R. E. Ruffin, C. Murgia, L. Li, S. A. Krilis, and P. D. Zalewski
Labile Zinc and Zinc Transporter ZnT4 in Mast Cell Granules: Role in Regulation of Caspase Activation and NF-{kappa}B Translocation
J. Immunol., June 15, 2004; 172(12): 7750 - 7760.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. O'Connor, S. D. Shumway, I. J. Amanna, C. E. Hayes, and S. Miyamoto
Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant I{kappa}B{alpha} Degradation in B Cells
Mol. Cell. Biol., June 1, 2004; 24(11): 4895 - 4908.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lewis, E. Burstein, S. B. Reffey, S. B. Bratton, A. B. Roberts, and C. S. Duckett
Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis
J. Biol. Chem., March 5, 2004; 279(10): 9023 - 9029.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. H. Nemeth, H. R. Wong, K. Odoms, E. A. Deitch, C. Szabo, E. S. Vizi, and G. Hasko
Proteasome Inhibitors Induce Inhibitory {kappa}B (I{kappa}B) Kinase Activation, I{kappa}B{alpha} Degradation, and Nuclear Factor {kappa}B Activation in HT-29 Cells
Mol. Pharmacol., February 1, 2004; 65(2): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Fluhrer, A. Friedlein, C. Haass, and J. Walter
Phosphorylation of Presenilin 1 at the Caspase Recognition Site Regulates Its Proteolytic Processing and the Progression of Apoptosis
J. Biol. Chem., January 16, 2004; 279(3): 1585 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Oakley, N. Trim, C. M. Constandinou, W. Ye, A. M. Gray, G. Frantz, K. Hillan, T. Kendall, R. C. Benyon, D. A. Mann, et al.
Hepatocytes Express Nerve Growth Factor during Liver Injury: Evidence for Paracrine Regulation of Hepatic Stellate Cell Apoptosis
Am. J. Pathol., November 1, 2003; 163(5): 1849 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Esposti, G. Ferry, P. Masdehors, J. A. Boutin, J. A. Hickman, and C. Dive
Post-translational Modification of Bid Has Differential Effects on Its Susceptibility to Cleavage by Caspase 8 or Caspase 3
J. Biol. Chem., April 25, 2003; 278(18): 15749 - 15757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Regula, K. Ens, and L. A. Kirshenbaum
IKKbeta Is Required for Bcl-2-mediated NF-kappa B Activation in Ventricular Myocytes
J. Biol. Chem., October 4, 2002; 277(41): 38676 - 38682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
O. Nyormoi, Z. Wang, D. Doan, M. Ruiz, D. McConkey, and M. Bar-Eli
Transcription Factor AP-2{alpha} Is Preferentially Cleaved by Caspase 6 and Degraded by Proteasome during Tumor Necrosis Factor Alpha-Induced Apoptosis in Breast Cancer Cells
Mol. Cell. Biol., August 1, 2001; 21(15): 4856 - 4867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Chen, V. Castranova, and X. Shi
New Insights into the Role of Nuclear Factor-{kappa}B in Cell Growth Regulation
Am. J. Pathol., August 1, 2001; 159(2): 387 - 397.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. Kreuz, D. Siegmund, P. Scheurich, and H. Wajant
NF-{kappa}B Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Mol. Cell. Biol., June 15, 2001; 21(12): 3964 - 3973.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
S. Pampfer, S. Cordi, S. Cikos, B. Picry, I. Vanderheyden, and R. D. Hertogh
Activation of Nuclear Factor {kappa}B and Induction of Apoptosis by Tumor Necrosis Factor-{alpha} in the Mouse Uterine Epithelial WEG-1 Cell Line
Biol Reprod, September 1, 2000; 63(3): 879 - 886.
[Abstract] [Full Text]


Home page
FASEB J.Home page
S. S. BAE, D. K. PERRY, Y. S. OH, J. H. CHOI, S. H. GALADARI, T. GHAYUR, S. H. RYU, Y. A. HANNUN, and P.-G. SUH
Proteolytic cleavage of phospholipase C-{gamma}1 during apoptosis in Molt-4 cells
FASEB J, June 1, 2000; 14(9): 1083 - 1092.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Schoonbroodt, V. Ferreira, M. Best-Belpomme, J. R. Boelaert, S. Legrand-Poels, M. Korner, and J. Piette
Crucial Role of the Amino-Terminal Tyrosine Residue 42 and the Carboxyl-Terminal PEST Domain of I{kappa}B{alpha} in NF-{kappa}B Activation by an Oxidative Stress
J. Immunol., April 15, 2000; 164(8): 4292 - 4300.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Granville, C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J.-Y. Matroule, J. Piette, and D. W. C. Hunt
Nuclear factor-kappa B activation by the photochemotherapeutic agent verteporfin
Blood, January 1, 2000; 95(1): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. de Moissac, H. Zheng, and L. A. Kirshenbaum
Linkage of the BH4 Domain of Bcl-2 and the Nuclear Factor kappa B Signaling Pathway for Suppression of Apoptosis
J. Biol. Chem., October 8, 1999; 274(41): 29505 - 29509.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. FADEEL, B. ZHIVOTOVSKY, and S. ORRENIUS
All along the watchtower: on the regulation of apoptosis regulators
FASEB J, October 1, 1999; 13(13): 1647 - 1657.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Y. Reuther and A. S. Baldwin Jr.
Apoptosis Promotes a Caspase-induced Amino-terminal Truncation of Ikappa Balpha That Functions as a Stable Inhibitor of NF-kappa B
J. Biol. Chem., July 16, 1999; 274(29): 20664 - 20670.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Walter, A. Schindzielorz, J. Grunberg, and C. Haass
Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis
PNAS, February 16, 1999; 96(4): 1391 - 1396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. R. Krishnamoorthy, M. J. Crawford, M. M. Chaturvedi, S. K. Jain, B. B. Aggarwal, M. R. Al-Ubaidi, and N. Agarwal
Photo-oxidative Stress Down-modulates the Activity of Nuclear Factor-kappa B via Involvement of Caspase-1, Leading to Apoptosis of Photoreceptor Cells
J. Biol. Chem., February 5, 1999; 274(6): 3734 - 3743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. A. Bradham, T. Qian, K. Streetz, C. Trautwein, D. A. Brenner, and J. J. Lemasters
The Mitochondrial Permeability Transition Is Required for Tumor Necrosis Factor Alpha-Mediated Apoptosis and Cytochrome c Release
Mol. Cell. Biol., November 1, 1998; 18(11): 6353 - 6364.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. P. Hehner, T. G. Hofmann, F. Ratter, A. Dumont, W. Droge, and M. L. Schmitz
Tumor Necrosis Factor-alpha -induced Cell Killing and Activation of Transcription Factor NF-kappa B Are Uncoupled in L929 Cells
J. Biol. Chem., July 17, 1998; 273(29): 18117 - 18121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Tang, R. Gururajan, and V. J. Kidd
Phosphorylation of PITSLRE p110 Isoforms Accompanies Their Processing by Caspases during Fas-mediated Cell Death
J. Biol. Chem., June 26, 1998; 273(26): 16601 - 16607.
[Abstract] [Full Text] [PDF]


Home page